[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-364682-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-364682-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","an-analysis-of-the-burden-of-respiratory-tract-cancers-in-global-china-the-united-states-and-india-findings-based-on-the-gbd-2021-database","An analysis of the burden of respiratory tract cancers in global, China, the United States and India - findings based on the GBD 2021 database","","This epidemiological study assesses the burden of respiratory tract cancers in China, the United States, India, and worldwide from 1990 to 2021, and forecasts deaths and DALYs for 2022 to 2050. Analyses use the GBD 2021 database and apply the Bayesian Age-Period-Cohort (BAPC) model to project trends. Results show declining ASR-Deaths and ASR-DALYs globally for laryngeal and TBL cancers, with increases in China and India for TBL cancer, stronger in females.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/an-analysis-of-the-burden-of-respiratory-tract-cancers-in-global-china-the-united-states-and-india-findings-based-on-the-gbd-2021-database/364682/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/an-analysis-of-the-burden-of-respiratory-tract-cancers-in-global-china-the-united-states-and-india-findings-based-on-the-gbd-2021-database/364682.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which cancers are covered in the analysis of respiratory tract cancers burden?","Question",{"text":63,"@type":64},"The study focuses on laryngeal cancer and TBL cancer (tracheal, bronchus, and lung cancer). TBL cancer is treated as predominant, while laryngeal cancer is included within respiratory tract cancers due to shared risk factors and anatomical continuity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What data and model are used to estimate historical trends and forecast future burden?",{"text":68,"@type":64},"The analysis is based on the GBD 2021 database covering 1990–2021. A Bayesian Age-Period-Cohort (BAPC) model is used to forecast deaths and DALYs for 2022–2050.",{"name":70,"@type":61,"acceptedAnswer":71},"How do trends differ across regions for TBL cancer and laryngeal cancer?",{"text":72,"@type":64},"ASR-Deaths and ASR-DALYs for laryngeal and TBL cancers decrease globally. The burden of TBL cancer increases in China and India, while laryngeal cancer declines in India; in the United States, both cancers decline substantially.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},364682,1790536885,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Liu et al. BMC Public Health (2025) 25:945 BMC Public Health  \n[https://doi.org/10.1186/s12889-025-21979-y](https://doi.org/10.1186/s12889-025-21979-y)  \nRESEARCH Open Access  \nAn analysis of the burden of respiratory tract  cancers in global, China, the United States and India: findings based on the GBD 2021 database  \nXinxin Liu 1†, Guoyu Wang 1,3†, Yafei Chen2†, Siyi Ma 1, Bozhen Huang 1, Shanshan Song 1, Luyao Wang 1, Wanqing Wang 1 and Min Jiang 1*  \nAbstract  \nObjective This study aimed to assess the burden of respiratory tract cancers in China, the United States, India, and worldwide from 1990 to 2021. Also, forecast the evolution of respiratory tract cancers deaths and DALYs burden during 2022 to 2050.  \nStudy design An epidemiological analysis.  \nMethods Based on the GBD 2021 data, this article analyzed and discussed the trends in burden of respiratory tract cancers in China, the United States, India, and the world from 1990 to 2021. Additionally, the Bayesian Age-PeriodCohort (BAPC) model was used to forecast the evolution of respiratory tract cancers deaths and DALYs burden during 2022 to 2050.  \nResults The ASR-Deaths and ASR-DALYs for laryngeal and TBL cancers decreased globally. The burden of disease for TBL cancer increased in China and India (AAPC: 0.38 and 0. 69), especially among Chinese women, while laryngeal cancer declined in India (AAPC: -0 . 69) . In contrast, the burden of disease for both cancers declined substantially in the United States (-1 . 82 AAPC for laryngeal cancer and − 1.74 AAPC forTBL) . A notable gender disparity existed in the burden of respiratory tumors, with males experienced a higher disease burden compared to females. In terms of age, the peak incidence of respiratory tract cancers predominantly occurred among individuals aged 65–74, indicating a clear tendency towards a higher prevalence among this age group. Population growth and ageing were primary factors influencing the mortality burden of larynx cancer, whereas epidemiological shifts inTBL cancer markedly impacted DALYs. The forecasted results for ASR-Deaths and ASR-DALYs worldwide from 2022 to 2050 indicated a decline in the burden of both larynx and TBL cancers. However, the deaths and DALYs ofTBL cancer in China will show an upward trend, especially for females.  \n†Xinxin Liu, Guoyu Wang andYafei Chen contributed equally asco-first authors.  \n*Correspondence: Min Jiang [jiangmin545@bjsjth.cn](jiangmin545@bjsjth.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nLiu et al. BMC Public Health (2025) 25:945 Page 2 of 18  \nConclusions The disease burden of respiratory tract cancers is a global health issue that needs attention, and situations vary from country to country, requiring personalized measures. Global strategies must address aging populations and socioeconomic disparities to reduce inequities in high-burden regions.  \nKeywords Res","cbCairnZg7EfpxCw","https://ap.wps.com/l/cbCairnZg7EfpxCw","pdf",9495153,18,"English","# Abstract\n# Introduction\n## Definition and scope of respiratory tract cancer\n## Epidemiology and risk factors\n# Methods\n## Data source and study design\n## Forecasting approach (BAPC)\n# Results\n## Global trends for laryngeal and TBL cancers\n## Regional differences: China, United States, India","[{\"question\":\"Which cancers are covered in the analysis of respiratory tract cancers burden?\",\"answer\":\"The study focuses on laryngeal cancer and TBL cancer (tracheal, bronchus, and lung cancer). TBL cancer is treated as predominant, while laryngeal cancer is included within respiratory tract cancers due to shared risk factors and anatomical continuity.\"},{\"question\":\"What data and model are used to estimate historical trends and forecast future burden?\",\"answer\":\"The analysis is based on the GBD 2021 database covering 1990–2021. A Bayesian Age-Period-Cohort (BAPC) model is used to forecast deaths and DALYs for 2022–2050.\"},{\"question\":\"How do trends differ across regions for TBL cancer and laryngeal cancer?\",\"answer\":\"ASR-Deaths and ASR-DALYs for laryngeal and TBL cancers decrease globally. The burden of TBL cancer increases in China and India, while laryngeal cancer declines in India; in the United States, both cancers decline substantially.\"}]","An analysis of the burden of respiratory tract cancers in global, China, the United States and India - findings based on the GBD 2021 database | PDF",1790158735,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0bd93d58607a33f0a6cdf6aee8062f74.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95ca6219ee84d489f9585e975e6fba7c.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed921359e0f93c53114ed967c85f2151.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a18f3fd55bfa64dcac7457ae4a9aba44.webp",980,1306]